DexCom, Inc. (DXCM)

業務介紹

德克斯康公司(DexCom, Inc.)是一家醫療器械公司,專注於在美國和國際上設計、開發和商業化持續性葡萄糖監測(CGM)系統。該公司為糖尿病患者以及醫療保健提供者提供其系統。其產品包括DexCom G6集成CGM系統、Dexcom Real-Time API(允許受邀的第三方開發者將實時CGM數據集成到他們的數字健康應用程序和設備中)、Dexcom ONE(旨在取代手指血糖檢測以進行糖尿病治療決策)以及Dexcom Share遠程監控系統。該公司的產品候選包括下一代G7 CGM系統Dexcom G7。德克斯康公司與Verily Life Sciences LLC和Verily Ireland Limited有合作和許可協議,以開發基於血液或組織間液的葡萄糖監測產品。該公司直接向內分泌科醫生、醫生和糖尿病教育者銷售其產品。德克斯康公司成立於1999年,總部位於加利福尼亞州聖地亞哥。



DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

公司網址

https://www.dexcom.com